Credit: Shutterstock photo(RTTNews.com) - Dr. Reddy's Laboratories Ltd (RDY) announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the U.S. Food and Drug Administration.
The Aggrenox brand and generic had U.S. sales of approximately $182 million MAT for the most recent twelve months ending in October 2018 according to IMS Health.
Dr. Reddy's Aspirin and Extended-Release Dipyridamole Capsules are available in 25 mg/200 mg strength with 60 count bottle size.
Read the original article on RTTNews (http://www.rttnews.com/2965151/dr-reddy-s-launches-aspirin-and-extended-release-dipyridamole-capsules-in-u-s.aspx)
For comments and feedback: contact editorial@rttnews.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
